ENTRY       D01713                      Drug
NAME        Epinastine hydrochloride (JAN);
            Alesion (TN);
            Elestat (TN)
PRODUCT
  GENERIC   EPINASTINE HYDROCHLORIDE (Breckenridge Pharmaceutical)
            EPINASTINE HYDROCHLORIDE (Somerset Therapeutics)
FORMULA     C16H15N3. HCl
EXACT_MASS  285.1033
MOL_WEIGHT  285.7713
CLASS       Anti-allergic agent
             DG01557  Histamine receptor antagonist
              DG01482  Histamine receptor H1 antagonist
            Dermatological agent
             DG03243  Atopic dermatitis agent
REMARK      Therapeutic category: 1319 4490
            ATC code: R06AX24 S01GX10
            Chemical structure group: DG01116
            Product (DG01116): D01713<JP/US>
EFFICACY    Antiallergic, H1 receptor antagonist
TARGET      HRH1 [HSA:3269] [KO:K04149]
  PATHWAY   hsa04080(3269)  Neuroactive ligand-receptor interaction
            hsa04750(3269)  Inflammatory mediator regulation of TRP channels
INTERACTION  
STR_MAP     map07212  Histamine H1 receptor antagonists
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             R RESPIRATORY SYSTEM
              R06 ANTIHISTAMINES FOR SYSTEMIC USE
               R06A ANTIHISTAMINES FOR SYSTEMIC USE
                R06AX Other antihistamines for systemic use
                 R06AX24 Epinastine
                  D01713  Epinastine hydrochloride (JAN) &lt;JP/US&gt;
             S SENSORY ORGANS
              S01 OPHTHALMOLOGICALS
               S01G DECONGESTANTS AND ANTIALLERGICS
                S01GX Other antiallergics
                 S01GX10 Epinastine
                  D01713  Epinastine hydrochloride (JAN) &lt;JP/US&gt;
            USP drug classification [BR:br08302]
             Ophthalmic Agents
              Ophthalmic Anti-Allergy Agents
               Antihistamine
                Epinastine
                 D01713  Epinastine hydrochloride (JAN)
            Therapeutic category of drugs in Japan [BR:br08301]
             1  Agents affecting nervous system and sensory organs
              13  Agents affecting sensory organs
               131  Ophthalmic agents
                1319  Others
                 D01713  Epinastine hydrochloride (JAN)
             4  Agents affecting cellular function
              44  Allergic agents
               449  Miscellaneous
                4490  Miscellaneous
                 D01713  Epinastine hydrochloride (JAN)
            Classification of Japanese OTC drugs [BR:br08313]
             Agents for otolaryngologic use
              69 Oral medicine for nasal inflammation
               D01713  Epinastine hydrochloride (JAN)
            Risk category of Japanese OTC drugs [BR:br08312]
             Second-class OTC drugs
              Inorganic and organic chemicals
               Epinastine
                D01713  Epinastine hydrochloride (JAN)
            Drug groups [BR:br08330]
             Anti-allergic agent
              DG01557  Histamine receptor antagonist
               DG01482  Histamine receptor H1 antagonist
                DG01116  Epinastine
                 D01713  Epinastine hydrochloride
             Dermatological agent
              DG03243  Atopic dermatitis agent
               D01713  Epinastine hydrochloride
            Drug classes [BR:br08332]
             Anti-allergic agent
              DG01482  Histamine receptor H1 antagonist
               D01713  Epinastine hydrochloride
             Dermatological agent
              DG03243  Atopic dermatitis agent
               D01713  Epinastine hydrochloride
            Target-based classification of drugs [BR:br08310]
             G Protein-coupled receptors
              Rhodopsin family
               Histamine
                HRH1
                 D01713  Epinastine hydrochloride (JAN) &lt;JP/US&gt;
            New drug approvals in the USA [br08319.html]
             New molecular entities and new therapeutic biological products
              D01713
            New drug approvals in the USA, Europe and Japan [br08328.html]
             Approval dates by FDA, EMA and PMDA
              D01713
            Rx-to-OTC switch list in Japan [br08314.html]
             D01713
            Drug groups [BR:br08330]
             Anti-allergic agent
              DG01557  Histamine receptor antagonist
               DG01482  Histamine receptor H1 antagonist
                DG01116  Epinastine
DBLINKS     CAS: 108929-04-0
            PubChem: 7848776
            ChEBI: 31533
            LigandBox: D01713
            NIKKAJI: J439.015F
ATOM        20
            1   C1y C    41.4777  -20.8394
            2   C8y C    40.6389  -21.9579
            3   C8y C    40.9884  -23.2861
            4   C1x C    42.2467  -23.8453
            5   N1y N    42.8758  -20.8394
            6   C8y C    43.4351  -23.2861
            7   C8y C    43.7846  -21.8880
            8   C8x C    39.9398  -24.2647
            9   C8x C    38.6116  -23.8453
            10  C8x C    38.2621  -22.5171
            11  C8x C    39.3107  -21.5385
            12  C8x C    45.1128  -21.4685
            13  C8x C    46.1614  -22.3773
            14  C8x C    45.8118  -23.7754
            15  C8x C    44.4836  -24.1948
            16  C1x C    40.9884  -19.5112
            17  N2x N    42.1069  -18.6723
            18  C2y C    43.2953  -19.4413
            19  N1a N    44.6235  -19.0219
            20  X   Cl   48.3983  -22.4472
BOND        22
            1     3   4 1
            2     1   5 1
            3     4   6 1
            4     2   3 1
            5     5   7 1
            6     1   2 1
            7     6   7 1
            8     3   8 2
            9     8   9 1
            10    9  10 2
            11   10  11 1
            12    2  11 2
            13    7  12 2
            14   12  13 1
            15   13  14 2
            16   14  15 1
            17    6  15 2
            18    1  16 1
            19   16  17 1
            20   17  18 2
            21    5  18 1
            22   18  19 1
///
